ACCP-ASHP Cardiology Pharmacy Preparatory Review Course Online Book, Online Course, CE 2026 (Videos + Audios + Slides)

The 2026 ACCP/ASHP cardiology pharmacy review takes pharmacists from cardiovascular prevention and risk assessment through complex heart failure and emergency care. Its seven modules cover lipid and blood pressure management, anticoagulation, rhythm disorders, transplantation, mechanical circulatory support, acute coronary syndromes, and pulmonary arterial hypertension. The final module connects clinical evidence with the practical work of running cardiology pharmacy services. Designed for BCCP examination preparation and a broader therapeutic refresher, the course uses patient cases to explore treatment selection, monitoring, and medication safety. Videos, audio recordings, and slides allow you to revisit individual subjects at your own pace.

File scope: This listing supplies Videos + Audios + Slides for self-paced study. It does not include provider registration, live attendance, publisher-platform access, accounts, apps, memberships, or publisher-hosted extras. References to official workbooks, assessments, or credit packages below describe the original offering, not additional store files.

Modules and Faculty

Module 1 – Primary Prevention of Cardiovascular Disease and Public Health; Dyslipidemia; Blood Pressure Management in Adult Patients

Module 1 Faculty

Carol Heunisch, Pharm.D., BCPS, BCCP

Director, Drug Policy and Education, North Region
Endeavor Health

Brandon E. Cave, Pharm.D., BCCP, AACC, AHSCP-CHC

Clinical Pharmacist Practitioner – Cardiology
West Palm Beach VA Healthcare System

Elisabeth M. Wang, Pharm.D., BCCP

Clinical Associate Professor
University of Houston College of Pharmacy

Module 2 – Stable Atherosclerotic Disease and Anticoagulation

Module 2 Faculty

Kelly C. Rogers, Pharm.D., FCCP, FACC, BCCP

Professor of Clinical Pharmacy and Translational Science
University of Tennessee College of Pharmacy

Paul P. Dobesh, Pharm.D., FCCP, FACC, FAHA, BCPS, BCCP

Professor of Pharmacy Practice and Science
University of Nebraska Medical Center College of Pharmacy

Module 3 – Arrhythmias; Drug-Induced Cardiovascular Disease and Drugs to Avoid in Cardiovascular Disease

Module 3 Faculty

Zachary R. Noel, Pharm.D., Ph.D., BCCP

Associate Professor
University of North Carolina at Chapel Hill Eshelman School of Pharmacy

Richard J. Rovelli, Pharm.D., BCCP

Cardiology Clinical Pharmacy Specialist
University of Maryland Medical Center

Genevieve M. Hale, Pharm.D., BCPS, BCCP, CPh

Associate Professor
Nova Southeastern University Barry and Judy Silverman College of Pharmacy

Module 4 – Chronic Heart Failure; Decompensated Heart Failure; Heart Transplant and Mechanical Circulatory Support

Module 4 Faculty

Theodore Berei, Pharm.D., MBA, FHFSA, BCCP

Clinical Specialist, Advanced Heart Failure and Transplant Cardiology
University of Wisconsin Hospitals and Clinics

Stormi E. Gale, Pharm.D., FHFSA, BCCP, BCPS

Clinical Pharmacy Specialist, Cardiovascular Intensive Care Unit
Atrium Health Carolinas Medical Center

Christina Ruggia-Check, Pharm.D., FAST, BCPS, BCCP, BCTXP

Clinical Pharmacy Specialist – CV Surgery/Heart Transplant
Temple University Hospital

Module 5 – Acute Coronary Syndrome and Cardiovascular Emergencies

Module 5 Faculty

Elizabeth Tien, Pharm.D., BCPS, BCCP

Clinical Pharmacy Specialist – Cardiology
UCSF Medical Center

Steven P. Dunn, Pharm.D., FCCP, FAHA, BCCP

Lead Pharmacist, Heart and Vascular
University of Virginia Health System

Module 6 – Pulmonary Arterial Hypertension and Specialized Topics in Cardiovascular Disease

Module 6 Faculty

James C. Coons, Pharm.D., FCCP, FACC, BCCP

Professor
University of Pittsburgh School of Pharmacy
Clinical Pharmacist, Cardiology, UPMC Presbyterian Hospital

Scott Bolesta, Pharm.D., FCCP, FCCM, BCCCP

Professor of Pharmacy Practice
Wilkes University

Module 7 – Translation of Evidence into Practice and Principles of Cardiology Pharmacy Practice Administration

Module 7 Faculty

William L. Baker, Pharm.D., FCCP, FACC, FHFSA

Professor of Pharmacy Practice
University of Connecticut School of Pharmacy

Ashley Schenk, Pharm.D., BCPS, BCCP, AACC

Cardiology Clinical Pharmacist
UK HealthCare
+ Topics:

• 01 Cardiovascular Disease Prevention – Lifestyle Modification, Risk Assessment, Tobacco Cessation, Pharmacotherapy, and Primary Prevention Strategies
• 02 Dyslipidemia Management – ASCVD Risk Assessment, Statins, Nonstatin Therapy, Hypertriglyceridemia, and Lipid Monitoring
• 03 Hypertension Pharmacotherapy – Blood Pressure Targets, Antihypertensive Selection, Combination Therapy, and Treatment Monitoring
• 04 Stable Atherosclerotic Cardiovascular Disease – Chronic Coronary Disease, Secondary Prevention, PAD, Stroke Prevention, and Long-Term Risk Reduction
• 05 Anticoagulation – Atrial Fibrillation, VTE, Mechanical Valves, DOACs, Warfarin, Bleeding Risk, and Therapeutic Monitoring
• 06 Cardiac Arrhythmias – Atrial and Ventricular Rhythm Disorders, Antiarrhythmic Drugs, QT Assessment, and Patient-Specific Pharmacotherapy
• 07 Drug-Induced Cardiovascular Disease – Cardiotoxicity, QT Prolongation, Torsades de Pointes, Oncology Therapies, and Medication-Related Cardiovascular Risk
• 08 Chronic Heart Failure – HFrEF, HFpEF, Guideline-Directed Medical Therapy, Comorbidity Management, and Evidence-Based Treatment
• 09 Acute Decompensated Heart Failure – Hemodynamic Assessment, Diuretics, Diuretic Resistance, Vasodilators, Inotropes, and Readmission Prevention
• 10 Heart Transplant Pharmacotherapy – Immunosuppression, Rejection Prevention, Drug Interactions, and Post-Transplant Medication Management
• 11 Mechanical Circulatory Support – LVAD, ECMO, Anticoagulation, Thromboprophylaxis, and Pharmacotherapy During Advanced Cardiac Support
• 12 Acute Coronary Syndrome – STEMI, NSTE-ACS, PCI, Antiplatelet Therapy, Anticoagulation, Reperfusion, and Secondary Prevention
• 13 Cardiac Arrest and Cardiovascular Emergencies – Resuscitation Pharmacotherapy, Shock Management, and Acute Hemodynamic Support
• 14 Hypertensive Crisis – Emergency Blood Pressure Reduction, Drug Selection, Monitoring, and Organ-Specific Treatment Strategies
• 15 Acute Aortic Syndrome – Emergency Cardiovascular Pharmacotherapy, Hemodynamic Control, and Treatment Planning
• 16 Acute Ischemic Stroke – Cardiovascular Pharmacotherapy Considerations and Evidence-Based Acute Treatment Planning
• 17 Pulmonary Arterial Hypertension – Classification, Risk Assessment, Targeted Therapy, Combination Treatment, and Decompensated PAH
• 18 Infective Endocarditis – Empiric Therapy, Definitive Treatment, Prophylaxis, and Cardiovascular Infection Management
• 19 Pericarditis – Evidence-Based Anti-Inflammatory Pharmacotherapy, Recurrence Prevention, and Treatment Monitoring
• 20 Myocarditis – Clinical Assessment, Supportive Pharmacotherapy, and Cardiovascular Management
• 21 Cardiovascular Clinical Trial Interpretation – Applying Study Design, Risk Estimates, and Contemporary Evidence to Patient Care
• 22 Translation of Evidence Into Practice – Integrating Guidelines, Trials, and Patient-Specific Factors Into Cardiovascular Pharmacotherapy
• 23 Cardiology Pharmacy Administration – Clinical Service Development, Documentation, Quality Improvement, and Interprofessional Practice
• 24 Cardiovascular Medication Safety – Drug Interactions, Adverse Effects, Monitoring, Cardiotoxicity, and High-Risk Pharmacotherapy
• 25 BCCP Board Examination Preparation – Case-Based Cardiovascular Clinical Reasoning, Self-Assessment, Practice Questions, and Specialty Review

Original Course Materials

The original ACCP/ASHP course describes more than 130 patient cases and more than 140 self-assessment questions with explained answers. Its media options include online workbook chapters, audio-synchronized slides, MP3 audio, MP4 video, PDF slides, a practice exam, references, and learning materials. The store package is limited to the formats stated above.

Official Continuing Pharmacy Education

The official 2026 course provides:

• 24.5 hours of Continuing Pharmacy Education (CPE)

Important dates:

• Release Date: June 17, 2026
• ACPE Deadline: June 17, 2029

The seven official module credits are:

• Module 1: 4.75 hours
• Module 2: 3.50 hours
• Module 3: 2.75 hours
• Module 4: 4.00 hours
• Module 5: 3.00 hours
• Module 6: 2.75 hours
• Module 7: 3.75 hours

Total: 24.50 CPE hours

Important Recertification Notice

The 2026 Cardiology Pharmacy Preparatory Review Course does NOT offer BCCP recertification credit.

Official CPE credit requires participation through the authorized ACCP/ASHP educational platform and successful completion of the applicable learning activities.